Your Trusted Source for Canadian News and Insights

Search keyWord:

HomeSearch

Aker Horizons ASA: Fourth-quarter results 2024

FORNEBU,Norway,Feb. 13,2025-- Aker Horizons ASA (OSE:AKH),a developer of green energy and industry,today announced results for the fourth quarter 2024. Aker Horizons\' net capital employed stood at NO

Feb 14, 2025
Hockey

DAAN Biotherapeutics Signs Antibody Exclusive Licensing Agreement with LigaChem Biosciences for ADC (Antibody-Drug Conjugate) Therapeutic Development

SEOUL,South Korea,Feb. 13,2025-- DAAN Biotherapeutics,a leading innovative drug development company specializing in T-cell receptor (TCR)- based therapies,has signed an exclusive licensing agreement w

Feb 14, 2025
Hockey

Polyplastics Launches New Eco-friendly PLASTRON (R) ︎LFT with Reduced Weight, Higher Rigidity, and Strong Damping

TOKYO,Feb. 13,2025-- Polyplastics Co.,Ltd.,a global leader in engineering plastics,has launched PLASTRON (R) LFT (long fiber-reinforced thermoplastic) RA627P,an eco-friendly composite of polypropylene

Feb 14, 2025
News

Cloud4C Secures Dual AI Specializations on Microsoft Azure, Strengthening AI Capabilities

SINGAPORE,Feb. 13,2025-- Cloud4C,a global leader in AI-driven cloud and cybersecurity services,has achieved two prestigious AI specializations on Microsoft Azure: \'AI Platform on Microsoft Azure\' an

Feb 14, 2025
News

Woolpert Welcomes Head of Strategic Growth, Asia-Pacific Susie Henderson

The accomplished global business executive will oversee the firm\'s strategic growth initiatives for the Asia-Pacific region.

Feb 14, 2025
Hockey

Alphamab Oncology Announces the First Patient Dosed in a Phase III Clinical Study for Ovarian Cancer of Anti-HER2 Bispecific ADC JSKN003

SUZHOU,China,Feb. 13,2025-- Alphamab Oncology (stock code: 9966.HK) announced that the first patient has been successfully dosed in the Phase III clinical study (Study ID: JSKN003-306) of anti-HER2 bi

Feb 14, 2025
News

CRIMSONLOGIC AND BDO SINGAPORE SIGN STRATEGIC PARTNERSHIP TO DEVELOP SPECIALIZED GENERATIVE AI ADVISORY PLATFORM

This strategic partnership aims to transform professional advisory services by leveraging cutting-edge Generative AI to provide accurate,domain-specific insights

Feb 14, 2025
Maple Syrup

Fujitsu to offer Fujitsu Cloud Service Generative AI Platform for secure and flexible enterprise data management

KAWASAKI,Japan,Feb. 13,2025-- Fujitsu today announced the launch of theFujitsu Cloud Service Generative AI Platform. The new service,which combines data confidentiality with the ease of use of the clo

Feb 14, 2025
Hockey

Restore Vision Announces First Patient Dosed in Phase I/II Clinical Trial of RV-001 for Gene-Agnostic Retinitis Pigmentosa

The first optogenetic "Chimeric Rhodopsin" gene therapy tested in humans. RV-001 starting dose was generally well tolerated in this open-label trial.

Feb 14, 2025
News

Happy Chinese New Year 2025: Jiangsu's Intangible Cultural Heritage Takes the Global Spotlight

NANJING,China,Feb. 13,2025-- On December 4th,2024,UNESCO inscribed the "Spring Festival,Social Practices of the Chinese People in Celebration of Traditional New Year" on its Representative L

Feb 14, 2025
Social
1 ... 309 310 311 312 313 314 315 ... 474